NOTICE

In light of the COVID-19 global pandemic, the Organising Committee has made the difficult decision to postpone the in-person Hippo Signalling in Development, Disease and New Therapies Conference, originally scheduled for 17 – 20 November 2020, to next year 16 – 19 November 2021 in Singapore.
 
In positive news, we are pleased to announce that we will still host a Hippo 2020 Virtual Conference on 18 & 19 November 2020 to share the latest developments in the Hippo field. We have assembled prominent Hippo researchers from around the world to discuss the latest insights into how this pathway controls development and disease, and how we can target it therapeutically in order to benefit patients with different diseases, most notably cancers. Please join in the virtual conference to learn the latest developments and interact with our speakers. For more information on the virtual conference, please visit this webpage: Hippo 2020 Virtual Conference
 
We look forward to your participation at both the virtual conference this year on 18 & 19 November 2020 and the in-person conference next year 16 – 19 November 2021.

For more information on the virtual conference, please press this button.

ORGANIZING COMMITTEE

Wanjin HONG
Institute of Molecular and Cell Biology (IMCB), A*STAR Research Entities, Singapore
 
Kieran HARVEY   
Peter MacCallum Cancer Centre, Australia &
Monash University, Australia
Marius SUDOL
Icahn School of Medicine at Mount Sinai
New York, USA
 

Supporters

Your corporate logo could impress here as well.
Contact us for support opportunities: Hippo2020@imcb.a-star.edu.sg